Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?

Clinical science (London, England : 1979) - 1 Jul 2001

Rustemeijer C, Schouten J A, Voerman H J, Beynen A C, Donker A J, Heine R J

Abstract excerpt

Hypertriglyceridaemia is a risk factor for cardiovascular disease in patients suffering from Type II diabetes mellitus, and is due to enhanced synthesis and/or impaired clearance of triacylglycerol-rich lipoproteins. In the present study we investigated whether pseudocholinesterase (PChE) activity could serve as a marker for the rate of triacylglycerol synthesis in these patients. Patients were stratified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Butyrylcholinesterase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Over Studies

Share to Hyperlipidemias

Share to Hypoglycemic Agents

Share to Linear Models

Share to Pravastatin

Share to Triglycerides

Source

Identifiers

PMID: 11410111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?PMID 11410111Read ↗

Butyrylcholinesterase and lipid metabolism: Possible dual role in metabolic disorders.Semantic proximity Read ↗

Butyrylcholinesterase activity and risk factors for coronary artery disease.Semantic proximity Read ↗

Physiological and Nutritional Regulation of Enzymes of Triacylglycerol SynthesisSemantic proximity Read ↗

Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?Semantic proximity Read ↗

Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes.Semantic proximity Read ↗

Butyrylcholinesterase activity and metabolic syndrome in obese patients.Semantic proximity Read ↗

Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.Semantic proximity Read ↗

The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.Semantic proximity Read ↗

Butyrylcholinesterase and diabetes mellitus in the CHE2 C5- and CHE2 C5+ phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.